Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report)’s share price rose 3.5% on Wednesday. The stock traded as high as $98.11 and last traded at $97.71. 70,566 shares were traded during trading, a decline of 87% from the average daily volume of 551,014 shares. The stock had previously closed at $94.44.
Wall Street Analyst Weigh In
BLLN has been the subject of a number of analyst reports. Weiss Ratings lowered Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, October 8th. Wall Street Zen downgraded Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. BTIG Research lowered their price objective on Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, August 6th. Zacks Research upgraded Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday, October 2nd. Finally, Guggenheim raised their target price on Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $126.25.
Read Our Latest Research Report on BLLN
Billiontoone Stock Up 3.3%
Billiontoone (NASDAQ:BLLN – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. The business had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. On average, sell-side analysts expect that Billiontoone, Inc. will post 0.83 EPS for the current year.
Insider Transactions at Billiontoone
In related news, CEO Oguzhan Atay sold 32,500 shares of Billiontoone stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.95, for a total value of $4,450,875.00. Following the completion of the sale, the chief executive officer owned 20,000 shares in the company, valued at approximately $2,739,000. This trade represents a 61.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $98.77, for a total value of $1,975,400.00. Following the completion of the sale, the chief technology officer directly owned 1,000 shares in the company, valued at approximately $98,770. The trade was a 95.24% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 218,691 shares of company stock worth $24,473,801. 50.22% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Billiontoone
Several hedge funds have recently bought and sold shares of the company. Toth Financial Advisory Corp boosted its holdings in Billiontoone by 60.0% during the 3rd quarter. Toth Financial Advisory Corp now owns 800 shares of the company’s stock valued at $85,000 after acquiring an additional 300 shares during the period. Family Legacy Financial Solutions LLC purchased a new stake in Billiontoone during the third quarter worth about $53,000. MCF Advisors LLC increased its stake in Billiontoone by 330.8% during the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock worth $54,000 after purchasing an additional 344 shares during the period. Integrated Wealth Concepts LLC purchased a new position in shares of Billiontoone in the second quarter valued at approximately $29,000. Finally, Thrive Wealth Management LLC purchased a new position in shares of Billiontoone in the second quarter valued at approximately $240,000.
Billiontoone Company Profile
BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.
BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.
Featured Articles
- Five stocks we like better than Billiontoone
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
- How a Hurricane Could Help Some Refineries—and Hurt Others
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
